|
Volume
19 Number 6
30 June 2017
|
|
Home
>
Publications
>
Current
Neuro-Oncology >
Volume
19, Year 2017 >
Number 6, 30 June
|
|
|
|
|
|
Sepúlveda-Sánchez
JM, Vaz MÁ, Balañá C, Gil-Gil M, Reynés
G, Gallego Ó, Martínez-García M, Vicente E,
Quindós M, Luque R, Ramos A, Ruano Y, Pérez-Segura
P, Benavides M, Sánchez-Gómez P, Hernández-Laín
A.
Phase
II trial of dacomitinib, a pan-HER (human epidermal growth factor
receptor) tyrosine kinase inhibitor, in recurrent glioblastoma
patients with EGFR amplification.
Neuro
Oncol. 2017 Jun 1, 2017;19(11):1522-1531→.
doi: 10.1093/neuonc/nox105→.
PMID: 28575464→.
Interventional
study. ˍ
|
|
|
|
Barkhoudarian
G.
A
feasibility study of the Nativis Voyager system in patients with
recurrent glioblastoma multiforme (GBM): Interim results of
first-in-human study.
J
Clin Oncol. 2017 Jun 2-6. 35, 2017 (suppl; abstr e13506)ˍ.
2017 ASCO Annual Meeting. Meeting
abstract. ˍ
|
|
|
|
Rizzo
A, Donzelli S, Girgenti V, Sacconi A, Vasco C, Salmaggi A,
Blandino G, Maschio M, Ciusani E.
In
vitro antineoplastic effects of brivaracetam and lacosamide on
human glioma cells.
J
Exp Clin Cancer Res. 2017 Jun 6, 2017;36(1):76→.
doi: 10.1186/s13046-017-0546-9→.
PMID:
28587680→.
Laboratory
investigation. ˍ
|
|
|
|
Al
Megren M, De Wit C, Al Qahtani M, Le Gal G, Carrier M.
Management
of venous thromboembolism in patients with glioma.
Thromb
Res. 2017 Jun 8, 2017;156:105-108→.
doi: 10.1016/j.thromres.2017.06.010→.
PMID: 28624717→.
Observational
study. ˍ
|
|
|
|
Li
ZG, Mu HY.
Extracranial
bone metastases from recurrent anaplastic astrocytoma on FDG
PET/CT: A case report a care-compliant article.
Medicine
(Baltimore). 2017 Jun [8], 2017;96(23):e7123→.
doi: 10.1097/MD.0000000000007123→.
PMID:
28591062→.
Case
report. ˍ
|
|
|
|
Kieran
MW, Chisholm J, Casanova M, Brandes AA, Aerts I, Bouffet E, Bailey
S, Leary S, MacDonald TJ, Mechinaud F, Cohen KJ, Riccardi R, Mason
W, Hargrave D, Kalambakas S, Deshpande P, Tai F, Hurh E, Geoerger
B.
Phase
I study of oral sonidegib (LDE225) in pediatric brain and solid
tumors and a phase II study in children and adults with relapsed
medulloblastoma.
Neuro
Oncol. 2017 Jun 9, 2017;19(11):1542-1552→.
doi: 10.1093/neuonc/nox109→.
PMID:
28605510→.
Interventional
study. ˍ
|
|
|
|
Nakajima
H, Furukawa C, Chang YC, Ogata H, Magae J.
Delayed
Growth Suppression and Radioresistance Induced by Long-Term
Continuous Gamma Irradiation.
Radiat
Res. 2017 Jun 9, 2017;188(2):181-190→.
doi: 10.1667/RR14666.1→.
PMID: 28598290→.
Laboratory
investigation. ˍ
|
|
|
|
Ng
I, Tan CL, Yeo TT, Vellayappan B.
Rapidly
Fatal Radiation-induced Glioblastoma.
Cureus.
2017 Jun 11, 2017;9(6):e1336→.
doi: 10.7759/cureus.1336→.
PMID:
28706761→.
Case
report. ˍ
|
|
|
|
Bavle
A, Parsons DW.
From
One to Many: Further Refinement of Medulloblastoma Subtypes Offers
Promise for Personalized Therapy.
Cancer
Cell. 2017 Jun 12, 2017;31(6):727-729→.
doi: 10.1016/j.ccell.2017.05.013→.
PMID: 28609651→.
Comment.
ˍ
Refers
to: Cavalli
FMG, et al., Intertumoral Heterogeneity within Medulloblastoma
Subgroups.
Cancer
Cell. 2017 Jun 12;31(6):737-754.e6→.
doi: 10.1016/j.ccell.2017.05.005→.
PMID: 28609654→.
Laboratory investigation. ˍ
|
|
|
⋆
|
Cavalli FMG, Remke M, Rampasek L,
Peacock J, Shih DJH, Luu B, Garzia L, Torchia J, Nor C, Morrissy
AS, Agnihotri S, Thompson YY, Kuzan-Fischer CM, Farooq H, Isaev K,
Daniels C, Cho BK, Kim SK, Wang KC, Lee JY, Grajkowska WA,
Perek-Polnik M, Vasiljevic A, Faure-Conter C, Jouvet A, Giannini
C, Nageswara Rao AA, Li KKW, Ng HK, Eberhart CG, Pollack IF,
Hamilton RL, Gillespie GY, Olson JM, Leary S, Weiss WA, Lach B,
Chambless LB, Thompson RC, Cooper MK, Vibhakar R, Hauser P, van
Veelen MC, Kros JM, French PJ, Ra YS, Kumabe T, López-Aguilar
E, Zitterbart K, Sterba J, Finocchiaro G, Massimino M, Van Meir
EG, Osuka S, Shofuda T, Klekner A, Zollo M, Leonard JR, Rubin JB,
Jabado N, Albrecht S, Mora J, Van Meter TE, Jung S, Moore AS,
Hallahan AR, Chan JA, Tirapelli DPC, Carlotti CG, Fouladi M,
Pimentel J, Faria CC, Saad AG, Massimi L, Liau LM, Wheeler H,
Nakamura H, Elbabaa SK, Perezpeña-Diazconti M, Chico Ponce
de León F, Robinson S, Zapotocky M, Lassaletta A, Huang A,
Hawkins CE, Tabori U, Bouffet E, Bartels U, Dirks PB, Rutka JT,
Bader GD, Reimand J, Goldenberg A, Ramaswamy V, Taylor MD.
Intertumoral
Heterogeneity within Medulloblastoma Subgroups.
Cancer
Cell. 2017 Jun 12;31(6):737-754.e6→.
doi: 10.1016/j.ccell.2017.05.005→.
PMID: 28609654→.
Laboratory investigation. ˍ
|
|
|
|
Kinon
MD, Scoco A, Farinhas JM, Kobets A, Weidenheim KM, Yassari R,
Lasala PA, Graber J.
Glioblastoma
multiforme presenting with an open ring pattern of enhancement on
MR imaging.
Surg
Neurol Int. 2017 Jun 13, 2017;8:106→.
doi: 10.4103/sni.sni_35_17→.
PMID:
28680725→.
Case
report. ˍ
|
|
|
|
Sattar
S, Akhunzada NZ, Javed G, Uddin Z, Khan YA.
Pilocytic
astrocytoma: A rare presentation as intraventricular tumor.
Surg
Neurol Int. 2017 Jun 13, 2017;8:116→.
doi: 10.4103/sni.sni_468_16→.
PMID:
28680735→.
Case
report. ˍ
|
|
|
|
Kepka
L, Tyc-Szczepaniak D, Osowiecka K, Sprawka A, Trąbska-Kluch
B, Czeremszynska B.
Quality
of life after whole brain radiotherapy compared with radiosurgery
of the tumor bed: results from a randomized trial.
Clin
Transl Oncol. 2017 Jun 14, 2018;20(2):150-159→.
doi: 10.1007/s12094-017-1703-5→.
PMID: 28616720→.
Interventional
study. ˍ
|
|
|
|
Frandsen
J, Orton A, Jensen R, Colman H, Cohen AL, Tward J, Shrieve DC,
Suneja G.
Patterns
of care and outcomes in gliosarcoma: an analysis of the National
Cancer Database.
J
Neurosurg. 2017 Jun 16, 2018;128(4):1133-1138→.
doi: 10.3171/2016.12.JNS162291→.
PMID: 28621623→.
Observational
study. ˍ
|
|
|
|
Gershanov
S, Michowiz S, Toledano H, Yahav G, Barinfeld O, Hirshberg A,
Ben-Zvi H, Mircus G, Salmon-Divon M, Fixler D, Goldenberg-Cohen N.
Fluorescence
Lifetime Imaging Microscopy, a Novel Diagnostic Tool for
Metastatic Cell Detection in the Cerebrospinal Fluid of Children
with Medulloblastoma.
Sci
Rep. 2017 Jun 16, 2017;7(1):3648→.
doi: 10.1038/s41598-017-03892-6→.
PMID:
28623325→.
Observational
study. ˍ.
|
|
|
|
Weller
M.
Surgery
for patients with "lower grade" glioma: putting
assumptions, beliefs and convictions into perspective.
Ann
Oncol. 2017 Jun 16, 2017;28(8):1696-1697→.
doi: 10.1093/annonc/mdx295→.
PMID: 28637247→.
Comment.
ˍ
Refers
to: Jakola
AS, et al., Surgical resection versus watchful waiting in
low-grade gliomas.
Ann
Oncol. 2017 May 5, 2017;28(8):1942-1948→.
doi: 10.1093/annonc/mdx230→.
PMID: 28475680→.
Observational
study. ˍ
|
|
|
|
Tsang
DS, Murphy ES, Ezell SE, Lucas JT Jr, Tinkle C, Merchant TE.
Craniospinal
irradiation for treatment of metastatic pediatric low-grade
glioma.
J
Neurooncol. 2017 Jun 17, 2017;134(2):317-324→.
doi: 10.1007/s11060-017-2525-6→.
PMID: 28623604→.
Observational
study.
ˍ
|
|
|
|
Kellermann
SG, Hamisch CA, Rueß D, Blau T, Goldbrunner R, Treuer H,
Grau SJ, Ruge MI.
Stereotactic
biopsy in elderly patients: risk assessment and impact on
treatment decision.
J
Neurooncol. 2017 Jun 21, 2017;134(2):303-307→.
doi: 10.1007/s11060-017-2522-9→.
PMID: 28639133→.
Observational
study.
ˍ
|
|
|
|
Gnekow
AK, Walker DA, Kandels D, Picton S, Giorgio Perilongo, Grill J,
Stokland T, Sandstrom PE, Warmuth-Metz M, Pietsch T, Giangaspero
F, Schmidt R, Faldum A, Kilmartin D, De Paoli A, De Salvo GL; of
the Low Grade Glioma Consortium and the participating centers.
A
European randomised controlled trial of the addition of etoposide
to standard vincristine and carboplatin induction as part of an
18-month treatment programme for childhood (≤16 years) low
grade glioma - A final report.
Eur
J Cancer. 2017 Jun 23, 2017;81:206-225→.
doi: 10.1016/j.ejca.2017.04.019→.
PMID: 28649001→.
Interventional
study. ˍ
|
|
|
|
Kim
WJ, Newman WC, Amankulor NM.
Phase
I/II Trial of Combination of Temozolomide Chemotherapy and
Immunotherapy With Fusions of Dendritic and Glioma Cells in
Patients With Glioblastoma.
Neurosurgery.
2017 Jun 23, 2017;81(1):N11→.
doi: 10.1093/neuros/nyx263→.
PMID: 28873996→.
Comment.
ˍ
Refers
to: Akasaki
Y et al., Phase I/II trial of combination of temozolomide
chemotherapy and immunotherapy with fusions of dendritic and
glioma cells in patients with glioblastoma.
Cancer Immunol
Immunother. 2016 Sep 29, 2016;65(12):1499-1509→.
doi: 10.1007/s00262-016-1905-7→.
PMID: 27688162→.
Interventional study. ˍ
|
|
|
*
|
Simonetti
G, Silvani A, Fariselli L, Hottinger AF, Pesce GA, Prada F,
Gaviani P.
Extra
central nervous system metastases from glioblastoma: a new
possible trigger event?
Neurol
Sci. 2017 Jun 24, 2017;38(10):1873-1875→.
doi: 10.1007/s10072-017-3036-0→.
PMID: 28647829→.
Case
report. ˍ
|
|
|
|
Tan
ZR, Long XY, Yang ZQ, Huang J, Hu QY, Yang HD, Li GL.
Younger
age at surgery and lesser seizure frequency as prognostic factors
for favorable seizure-related outcome after glioma resection in
adults.
Oncotarget.
2017 Jun 27, 2017;8(55):93444-93449→.
doi: 10.18632/oncotarget.18726→.
PMID: 29212163→.
Observational
study. ˍ
|
|
|
|
Grossman
SA, Kleinberg L.
A
search for the "Goldilocks zone" with regard to the
optimal duration of adjuvant temozolomide in patients with
glioblastoma.
Neuro
Oncol. 2017 Jun 30, 2017;19(8):1019-1020→.
doi: 10.1093/neuonc/nox046→.
PMID: 28854621→.
Editorial.
ˍ
Refers
to: Blumenthal
DT et al., Is more better? The impact of extended
adjuvant temozolomide in newly diagnosed glioblastoma: a secondary
analysis of EORTC and NRG Oncology/RTOG.
Neuro
Oncol. 2017 Mar 24, 2017;19(8):1119-1126→.
doi: 10.1093/neuonc/nox025→.
PMID: 28371907→.
Observational
study. ˍ
|
|
|
|
|
|
|
|
|
